HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Steven B Maron Selected Research
Steven B Maron Research Topics
Disease
26
Neoplasms (Cancer)
03/2024 - 01/2017
16
Adenocarcinoma
10/2023 - 01/2017
11
Stomach Neoplasms (Stomach Cancer)
03/2024 - 01/2020
3
Microsatellite Instability
01/2023 - 11/2019
2
Disease Progression
01/2023 - 10/2022
2
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2020
2
Leukemia
01/2023 - 01/2023
1
Turcot syndrome
01/2024
1
Melanoma (Melanoma, Malignant)
10/2023
1
Lung Neoplasms (Lung Cancer)
10/2023
1
Infections
10/2023
1
Pathologic Complete Response
06/2023
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023
1
Atherosclerosis
01/2023
1
Carcinoma (Carcinomatosis)
12/2022
1
Obesity
11/2021
1
Lymphopenia (Lymphocytopenia)
01/2020
1
Colorectal Neoplasms (Colorectal Cancer)
01/2019
1
Colonic Neoplasms (Colon Cancer)
12/2018
Drug/Important Bio-Agent (IBA)
5
Biomarkers (Surrogate Marker)
IBA
03/2024 - 01/2020
5
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 11/2019
5
Trastuzumab (Herceptin)
FDA Link
01/2023 - 11/2019
4
Immune Checkpoint Inhibitors
IBA
01/2024 - 01/2023
4
pembrolizumab
IBA
01/2023 - 02/2018
4
Circulating Tumor DNA
IBA
01/2023 - 01/2018
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
03/2024 - 01/2023
2
Nivolumab
IBA
10/2023 - 01/2022
2
zirconium-89-trastuzumab
IBA
01/2023 - 01/2023
2
Phosphotransferases (Kinase)
IBA
01/2022 - 11/2019
2
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 01/2022
2
tyrosine receptor (receptor, tyrosine)
IBA
01/2022 - 11/2019
2
Ramucirumab
IBA
01/2020 - 01/2019
1
B7-H1 Antigen
IBA
03/2024
1
Albumins
IBA
03/2024
1
Antigens
IBA
10/2023
1
regorafenib
IBA
10/2023
1
Trinitrotoluene (TNT)
IBA
06/2023
1
human ERBB2 protein
IBA
01/2023
1
Small Cytoplasmic RNA
IBA
01/2023
1
durvalumab
IBA
01/2023
1
Indicators and Reagents (Reagents)
IBA
12/2022
1
Carcinogens
IBA
10/2022
1
Exonucleases (3' 5' Exonuclease)
IBA
01/2022
1
atezolizumab
IBA
01/2022
1
Electrolytes
IBA
01/2020
1
Antral
IBA
01/2020
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2019
1
Platinum
IBA
01/2019
1
Irinotecan (Camptosar)
FDA Link
Generic
12/2018
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2018
1
Leucovorin (Folinic Acid)
FDA Link
12/2018
1
Cetuximab (Erbitux)
FDA Link
12/2018
1
Fluorouracil (Carac)
FDA Link
Generic
12/2018
1
Monoclonal Antibodies
IBA
02/2018
Therapy/Procedure
17
Therapeutics
06/2023 - 01/2017
10
Drug Therapy (Chemotherapy)
10/2023 - 02/2018
6
Neoadjuvant Therapy
06/2023 - 09/2021
3
Immunotherapy
10/2023 - 01/2022
2
Adjuvant Chemotherapy
01/2023 - 12/2018
1
Radiotherapy
01/2023
1
Induction Chemotherapy
01/2023
1
Esophagectomy
01/2023
1
Gastrectomy
11/2021
1
Metastasectomy
01/2020